IXICO PLC

IXI

Delayed - 01/15 11:35:00 am
91GBX	+2.25%

Turn to zoom

Prev.	89.0000
Open	89.0000
High	91.0000
Low	88.0500
Volume	110 071

12/24	Ixico : Expands Rare Disease Franchise With $5 Million Contract Win
12/08	IXICO Secures Contract for Orphan Drug Clinical Trial for Huntington's...
12/02	Earnings Flash (IXI.L) IXICO Reports FY20 Revenue GBP9.5M
12/02	Earnings Flash (IXI.L) IXICO Posts FY20 EPS GBX2.00

	Short Term	Mid-Term	Long Term
Trend	Bearish	Bullish	Bullish
Resistance	99,5	124	118
Spread/Res.	-8,5%	-26%	-23%
Spread/Supp.	2,2%	2,2%	23%
Support	89,0	89,0	74,0

Sales 2020	9,32 M 12,7 M 12,7 M
Net income 2020	0,70 M 0,96 M 0,96 M
Net cash 2020	7,65 M 10,4 M 10,4 M
P/E ratio 2020	60,7x
Yield 2020	-

Capitalization	42,9 M 58,3 M 58,3 M
EV / Sales 2020	3,78x
EV / Sales 2021	3,66x
Nbr of Employees	82
Free-Float	61,9%

IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa,...

>> Read more

Sector :

Biotechnology & Medical Research - NEC

Calendar :

2021-01-21 Shareholder meeting

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	2
Average target price	117,00 GBX
Last Close Price	91,00 GBX
Spread / Highest target	28,6%
Spread / Average Target	28,6%
Spread / Lowest Target	28,6%